[go: up one dir, main page]

NO952289L - Substituerte benzazepinoner - Google Patents

Substituerte benzazepinoner

Info

Publication number
NO952289L
NO952289L NO952289A NO952289A NO952289L NO 952289 L NO952289 L NO 952289L NO 952289 A NO952289 A NO 952289A NO 952289 A NO952289 A NO 952289A NO 952289 L NO952289 L NO 952289L
Authority
NO
Norway
Prior art keywords
aryl
alkyl
alkoxy
substituted
cycloalkyl
Prior art date
Application number
NO952289A
Other languages
English (en)
Other versions
NO952289D0 (no
Inventor
Peter Buhlmayer
Pascal Furet
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO952289D0 publication Critical patent/NO952289D0/no
Publication of NO952289L publication Critical patent/NO952289L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Substituerte 3-ajnino-l-arylalkyl-benzazepin-2-oner med generell formel R1 R, (D. Ar der Ar betyr aryl; X betyr C1-C2-alkylen eller står for en direkte- binding; Rx betyr hydrogen, laverealkyl, aryl-laverealkyl eller acyl; R2 betyr laverealkyl. hydroksylaverealkyl, laverealkoksylaverealkyl, aryllaverealkoksylaverealkyl, aryl-laverealkyl eller C3-C7-cykloalkyl- laverealkyl; R3 betyr karboksy, 5-tetrazolyl, P02H2, P03H2 eller S03H2; laverealkoksykarbonyl; lalverealkoksy-laverealkoksykarbonyl; aryl- laverealkoksykarbonyl; aryloksykarbonyl; karbamoyl; karbamoyl som (l) er monosubstituert med hydroksy, laverealkansulfonyl, halogenlaverealkansulfonyl eller arylsulfonyl, (il) monosubstituert eller uavhengig av hverandre disubstituert med laverealkyl, laverealkenyl, laverealkinyl, fenyllaverealkyl eller (ill) disubstituert med laverealkylen eller laverealkylen-Xj^-laverealkylen. der Xi står for O, S eller NH; ringen A er usubstituert eller en eller flere ganger substituert med substituenter valgt fra gruppen bestående av: laverealkyl, aryllaverealkyl, laverealkoksy-laverealkyl, laverealkoksy, laverealkoksy-laverealkoksy, aryllaverealkoksy, C3-C7-cykloalkyl, C3- C7-cykloalkyl-laverealkyl, nitro, halogen, trifluormetyl, amlno, amino : som er mono- eller uavhengig av hverandre disubstituert med laverealkyl, aryllaverealkyl eller aryl, eller disubstituert med laverealkylen eller laverealkylenoksylaverealkylen; eller et salt derav; fremgangsmåte for fremstilling; deres anvendelse så vel som farmasøytiske preparater som inneholder forbindelsen med formel (I) eller farmasøytisk anvendbare salter derav.
NO952289A 1992-12-11 1995-06-09 Substituerte benzazepinoner NO952289L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH380292 1992-12-11
PCT/EP1993/003425 WO1994013642A1 (de) 1992-12-11 1993-12-06 Substituierte benzazepinone

Publications (2)

Publication Number Publication Date
NO952289D0 NO952289D0 (no) 1995-06-09
NO952289L true NO952289L (no) 1995-06-09

Family

ID=4263766

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952289A NO952289L (no) 1992-12-11 1995-06-09 Substituerte benzazepinoner

Country Status (11)

Country Link
US (1) US5683997A (no)
EP (1) EP0673369A1 (no)
JP (1) JPH08506097A (no)
KR (1) KR950704259A (no)
AU (1) AU685767B2 (no)
CA (1) CA2151380A1 (no)
FI (1) FI952804A7 (no)
HU (1) HUT71557A (no)
NO (1) NO952289L (no)
NZ (1) NZ258888A (no)
WO (1) WO1994013642A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2339662A1 (en) 1998-08-07 2000-02-17 Takeda Chemical Industries, Ltd. Benzothiepin derivatives, their production and use
US6465502B1 (en) * 1998-12-23 2002-10-15 Novartis Ag Additional therapeutic use
EP1013273A1 (en) * 1998-12-23 2000-06-28 Novartis AG Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
ID29856A (id) 1998-12-23 2001-10-18 Novartis Ag Penggunaan antagonis reseptor at-1 atau modulator reseptor at-2 untuk mengobati penyakit yang berkaitan dengan peningkatan reseptor-reseptor at-1 atau at-2
IT1308613B1 (it) 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
US6211217B1 (en) 1999-03-16 2001-04-03 Novartis Ag Method for reducing pericardial fibrosis and adhesion formation
US8642051B2 (en) * 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
EP1382334A1 (en) * 2002-07-11 2004-01-21 Université de Picardie Jules Verne Use of angiotensin II AT1-receptor blockers (ARB), alone or combined with thiazide or angiotensin II for the treatment of stroke
US20060024241A1 (en) * 2004-08-02 2006-02-02 Bebaas, Inc. Vitamin B12 compositions
CN102049048B (zh) 2004-12-24 2013-12-25 西芬克斯医药有限公司 治疗或预防的方法
US20130131007A1 (en) 2005-09-07 2013-05-23 Bebaas, Inc. Vitamin b12 compositions
US20070178141A1 (en) * 2005-09-07 2007-08-02 Bebaas, Inc. Vitamin B12 compositions
CN102885818B (zh) * 2006-03-20 2016-05-04 诺华股份有限公司 治疗或预防炎性痛的方法
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1266647A (en) * 1984-06-26 1990-03-13 William H. Parsons Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
DE3586445T2 (de) * 1984-06-26 1993-01-14 Merck & Co Inc Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen.
US5206235A (en) * 1991-03-20 1993-04-27 Merck & Co., Inc. Benzo-fused lactams that promote the release of growth hormone

Also Published As

Publication number Publication date
AU685767B2 (en) 1998-01-29
CA2151380A1 (en) 1994-06-23
HU9501695D0 (en) 1995-08-28
FI952804A0 (fi) 1995-06-07
FI952804A7 (fi) 1995-06-07
HUT71557A (en) 1995-12-28
KR950704259A (ko) 1995-11-17
AU5696694A (en) 1994-07-04
JPH08506097A (ja) 1996-07-02
NZ258888A (en) 1997-02-24
NO952289D0 (no) 1995-06-09
WO1994013642A1 (de) 1994-06-23
US5683997A (en) 1997-11-04
EP0673369A1 (de) 1995-09-27

Similar Documents

Publication Publication Date Title
NO952289L (no) Substituerte benzazepinoner
SK278365B6 (en) Therapeuticly effective xanthine derivative, preparation method thereof and pharmaceutical agent containing its
MXPA05003193A (es) Compuesto de adenina novedoso y uso del mismo.
MX9709951A (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
MY114679A (en) Aroyl-piperidine derivatives
NO955074L (no) 1-substituerte istain- og oksindolderivater som inhibitorer til acetylkolinesterase
NO855355L (no) Fremgangsmaate for fremstilling av naftalenderivater.
FI810250L (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva heterocykliska foereningar
PT1216245E (pt) Derivados sulfonil-hidrazida farmaceuticamente activos
NO892295D0 (no) Fremgangsmaate for fremstilling av nye cefemforbindelser.
IE33862B1 (en) Thiepin and oxepin derivatives,processes for their production and medicaments containing same
NO963655L (no) Nye aminosyrederivater, fremgangsmåte for fremstilling av dem og farmasöytiske blandinger som inneholder dem
AR027454A1 (es) Derivados de beta-alanina, utiles como antagonistas de receptores, las composiciones farmaceuticas que las contienen y el uso de los mismos para lapreparacion de medicamentos
NO952288L (no) Benzazepinon-derivater
MX9405111A (es) Nuevos derivados de (1-fenil-1-heterociclil)metanol y(1-fenil-1-heterociclil-metilamina).
GB1453417A (en) Nitroimidazoles
ATE42295T1 (de) Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen.
ES8602762A1 (es) Metodo de obtener compuestos utiles como agentes inhibidores de la agregacion de plaquetas
IL91541A0 (en) Aryloxy-,arylthio-,heteroaryloxy-,and heteroarylthioalkenylene derivatives of amines,their preparation and pharmaceutical compositions containing them
HUP0001727A2 (hu) Új 1-aza-2-alkil-6-aril-cikloalkán-származékok, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények
BR0209963A (pt) Derivados tricìclicos de dihidro-quinoleìnas, o respectivo processo de preparação e as composições farmacêuticas que os contêm
HUP0100407A2 (hu) Eljárás kinolin-karbamoil- és kinolin-tiokarbamoil-származékok előállítására és az eljárás intermedierjei
GB1385639A (en) Basically substituted coumarin derivatives
ES368607A1 (es) Un procedimiento para la produccion de compuestos seleccio-nados del grupo de los 1-sustituido-2,5-difenilpirroles.
GB1493333A (en) Beta-etherified-phenethylamino-pyrrolidines